Medical Devices: Page 49
-
Getty Images
Baxter completes biopharma solutions sale, business unit revamp
The company plans to use most of the $3.7 billion in after-tax proceeds from the biopharma solutions sale to repay debt.
By Susan Kelly • Nov. 2, 2023 -
Courtesy of Cook Medical
CooperCompanies buys reproductive health products from Cook Medical after failed takeover
The company paid $300 million to buy certain maternal fetal medicine and gynecological surgery products.
By Elise Reuter • Nov. 2, 2023 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Lukas Schulze/Getty Images via Getty Images
FDA extends pandemic-era policy allowing certain device, production changes without prior approval
Companies can make limited modifications on certain devices and manufacturing processes to address supply shortages or production limitations.
By Ricky Zipp • Nov. 2, 2023 -
Mario Tama via Getty Images
Drilling down on obesity drugs: What medtech executives are saying
Investor concerns that interest in GLP-1s will slow demand for medical devices and procedures have shaved roughly $370 billion in value from stocks across the medtech sector, according to research by Mizuho.
By Susan Kelly • Nov. 2, 2023 -
Chip Somodevilla via Getty Images
White House orders HHS to start collecting reports on the safety of AI in healthcare
President Joe Biden outlined the planned program as part of an executive order on “safe, secure, and trustworthy” artificial intelligence.
By Nick Paul Taylor • Nov. 1, 2023 -
Courtesy of Stryker
Q&AStryker’s Lisa Kloes talks cementless implants, robotics as future of knee business
The manager of Stryker’s knee business also discussed the growing role of ambulatory surgery centers in orthopedics.
By Elise Reuter • Updated Nov. 8, 2023 -
Sarah Silbiger/Getty Images via Getty Images
FDA warning letter accuses Wavi of selling unapproved neurological device
Wavi markets its headset as providing a baseline scan for patients who have a traumatic event, an injury or are worried about their brain as they age.
By Nick Paul Taylor • Nov. 1, 2023 -
Stringer via Getty Images
GE HealthCare sales resilient despite ‘highly volatile’ economy
The company raised its earnings forecast for 2023 as it outlined plans to expand margins and navigate China's anti-corruption campaign.
By Elise Reuter • Oct. 31, 2023 -
Patrik Stollarz / Staff via Getty Images
11 key moments in Philips’ massive recall of respiratory devices
The recall of millions of sleep apnea devices and ventilators is still ongoing more than two years later, as Philips works to repair and replace affected machines.
By Elise Reuter • Oct. 31, 2023 -
IOS/Zuma Press/Newscom
TrackerTracking Philips Respironics recalls
Philips recalled its Trilogy ventilators to fix new and previously reported problems with the machines. The company issued a mandatory software update and changed the devices’ instructions.
By Elise Reuter • Updated Oct. 3, 2024 -
Sean Gallup via Getty Images
FDA posts updated safety data on Bayer’s Essure, notes progress on improving study
The agency removed the “inadequate” progress tag it applied last year after Bayer acted to get people back in the study.
By Nick Paul Taylor • Oct. 31, 2023 -
4 medtech companies to watch this week in earnings
GE HealthCare and Stryker are among the top medtech companies posting financial results in the third week of this earnings season.
By Susan Kelly • Oct. 30, 2023 -
Courtesy of ResMed
Resmed cuts 5% of staff amid profitability push
The company has stopped some projects that were not working well as it seeks to cut operating costs, CEO Mick Farrell told investors.
By Elise Reuter • Oct. 30, 2023 -
Permission granted by Philips
Philips leader signed off on sale of respiratory devices despite evidence of health risks: report
Roy Jakobs approved the sale of respiratory devices held by manufacturers after the company stopped shipping new machines, according to an article published last week by Pittsburgh Post-Gazette and ProPublica.
By Nick Paul Taylor • Oct. 30, 2023 -
Getty Images
Masimo prevails against Apple in USITC patent investigation
The patent dispute over pulse oximetry functions could result in a ban on imports of some Apple Watches.
By Susan Kelly • Oct. 27, 2023 -
Courtesy of Edwards Lifesciences
Edwards posts early look at tricuspid device, stoking Abbott rivalry ahead of FDA panel
Nearly 94% of patients had their condition improve to mild or no tricuspid regurgitation six months after treatment, according to the study.
By Nick Paul Taylor • Oct. 27, 2023 -
Permission granted by Baxter International
Q&ABaxter’s Heather Knight talks combating sepsis — and how AI can help
The company’s group president for medical products and therapies says the right fluid management practices can help save lives and lower hospital costs.
By Susan Kelly • Oct. 27, 2023 -
Getty Images
GE HealthCare’s imaging AI will become ‘increasingly meaningful’ to growth: Moody’s
Even if modestly accretive, AI could support longer-term revenue targets at GE HealthCare and its competitors, Moody’s analysts wrote.
By Nick Paul Taylor • Oct. 27, 2023 -
Getty Images
Accuray lays off nearly 6% of radiotherapy workforce
The company delivered fourth quarter results that fell short of analyst expectations in August, causing its share price to fall.
By Nick Paul Taylor • Oct. 27, 2023 -
Courtesy of Boston Scientific
Boston Scientific looks to new devices in 2024 to drive growth
The company expects to receive FDA approval for its Agent drug-coated balloon and its Farapulse pulsed-field ablation system next year.
By Elise Reuter • Oct. 26, 2023 -
Courtesy of Abbott
Abbott’s resorbable scaffold improves outcomes in below-the-knee artery disease, study finds
The device maker plans to submit the Esprit BTK data to the Food and Drug Administration for review.
By Nick Paul Taylor • Oct. 26, 2023 -
Permission granted by Boston Scientific
Boston Scientific study results support coronary drug-coated balloon in US
The results, shared at TCT 2023, found the company’s drug-coated balloon performed better than an uncoated balloon in procedures to reopen blocked arteries.
By Elise Reuter • Oct. 25, 2023 -
Getty Images
Edwards, Medtronic post low-risk TAVR data, allaying fears of market disruption
The late-breaking results, shared at TCT 2023, will have little impact on clinical practice or market share, J.P. Morgan and Stifel analysts predicted.
By Nick Paul Taylor • Oct. 25, 2023 -
Thermo Fisher cuts 2023 forecast, citing volatile economic conditions
Customer spending remains constrained overall, while economic conditions in China have weakened, CEO Marc Casper said on a Wednesday earnings call.
By Susan Kelly • Oct. 25, 2023 -
Getty Images
GE HealthCare, Novo Nordisk partner to use ultrasound to treat diabetes, obesity
The collaborators will study the use of peripheral focused ultrasound as a non-invasive, non-pharmacological method of managing blood glucose.
By Nick Paul Taylor • Oct. 25, 2023
Previous
